MAPT and Alzheimer disease: In contrast, phosphorylated, misfolded and total tau was significantly reduced in the sarkosyl-insoluble fraction (Figures 4C,D) of YZT-treated groups but not in the vehicle-treated group of 3XTg-AD mice.